---
category: news
title: "GT Apeiron Announces Enrollment of First Patient in Phase 1/2 \"ELUCIDATE\" Clinical Trial of CDK7 Inhibitor, GTAEXS617, in Advanced Solid Tumors"
excerpt: "Both the monotherapy and combination therapy dose escalation portion of the trial ... GT Apeiron is redefining medical discovery, using artificial intelligence to streamline the drug development processâ€”from target selection to clinical trials."
publishedDateTime: 2023-07-10T10:59:00Z
originalUrl: "https://www.benzinga.com/pressreleases/23/07/g33163133/gt-apeiron-announces-enrollment-of-first-patient-in-phase-12-elucidate-clinical-trial-of-cdk7-inhi"
webUrl: "https://www.benzinga.com/pressreleases/23/07/g33163133/gt-apeiron-announces-enrollment-of-first-patient-in-phase-12-elucidate-clinical-trial-of-cdk7-inhi"
ampWebUrl: "https://www.benzinga.com/amp/content/33163133"
cdnAmpWebUrl: "https://www-benzinga-com.cdn.ampproject.org/c/s/www.benzinga.com/amp/content/33163133"
type: article
quality: 8
heat: 8
published: false

provider:
  name: Benzinga.com
  domain: benzinga.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://www.benzinga.com/next-assets/images/schema-image-default.png"
    width: 1043
    height: 1043
    isCached: true

secured: "oCGdTJ8Pyd+xlc+rAJlG8aFW8+PefQKIsJwmtcb/XwrX4P2MNviLN2Cc3wF5wFOo9J+hbcRjODoZjg+LuZOy5FPaDGBuWgli95mBjGlFWlJ1ZkYlufQXb9q+qP7ATqVqphtGzHfS6PzDmVk22NFeR/xcjfI+KTn2lA0zuLlT5/raUfkdmYtayVYFZIy7346XmG7rqtRNK6L7yuGpYVlIwhIOzKQKTcJ4y3ApOkVx+BBbHcavrNzDTiMEwuuiZRXCLuQ2q8qlFgE3nAg7DVzY7pPBq1LV8oK7irlgi44zFnftIkSY6FYdjqeilDGPo3zRe3vFsW7FIcr7rtjrJ2rD6kz6vC5RWq1a3ADtsX3dpQY=;s09IYt6APjru+c65e+PA7Q=="
---

